An open label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel (nab-PAC) with or without the anti-death receptor 5 monoclonal antibody tigatuzumab in patients with metastatic triple negative breast cancer

Academic Article


Published In

Author List

  • Vaklavas C; Abramson VG; Lin NU; Lin MC; Rugo HS; Nanda R; Storniolo AM; Traina TA; Li Y; Patil S
  • Volume

  • 31
  • Issue

  • 15